Alltracel seals deal with HemCon

MEDICAL technology company, Alltracel has announced that its Nanopeutics subsidiary has signed an exclusive technology and product concept development with US company, HemCon Medical Technologies — a market leader in haemorrhage control in the military market.

The development work is expected to lead to a licence and supply agreement for a range of chitosan-based Nanospider woundcare technologies and products for exclusively military market usage.